Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorSantoro, Francesco
dc.contributor.authorArcari, Luca
dc.contributor.authorEl-Battrawy, Ibrahim
dc.contributor.authorNuñez Gil, Ivan Javier
dc.contributor.authorPätz, Toni
dc.contributor.authorAbumayyaleh, Mohammad
dc.contributor.authorUribarri, Aitor
dc.date.accessioned2024-02-21T07:54:50Z
dc.date.available2024-02-21T07:54:50Z
dc.date.issued2024-02-20
dc.identifier.citationEl-Battrawy I, Santoro F, Núñez-Gil IJ, Pätz T, Arcari L, Abumayyaleh M, et al. Age-Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry. J Am Heart Assoc. 2024 Feb 20;13(4):e030623.
dc.identifier.issn2047-9980
dc.identifier.urihttps://hdl.handle.net/11351/11091
dc.descriptionAge variation; Takotsubo syndrome
dc.description.abstractBackground The role of age in the short‐ and long‐term prognosis of takotsubo syndrome (TTS) is controversial. The aim of the present study was to evaluate age‐related differences and prognostic implications among patients with TTS. Methods and Results In total, 2492 consecutive patients with TTS enrolled in an international registry were stratified into 4 groups (<45, 45–64, 65–74, and ≥75 years). The median long‐term follow‐up was 480 days (interquartile range, 83–1510 days). The primary outcome was all‐cause mortality (in‐hospital and out‐of‐hospital mortality). The secondary end point was TTS‐related in‐hospital complications. Among the 2479 patients, 58 (2.3%) were aged <45 years, 625 (25.1%) were aged 45 to 64 years, 733 (29.4%) were aged 65 to 74 years, and 1063 (42.6%) were aged ≥75 years. Young patients (<45 years) had a higher prevalence of men (from youngest to oldest, 24.1% versus 12.6% versus 9.7% versus 11.4%; P<0.01), physical triggers (46.6% versus 27.5%, 33.9%, and 38.4%; P<0.01), and non‐apical forms of TTS (25.9% versus 23.7%, 12.7%, and 9%; P<0.01) than those aged 45 to 64, 65 to 74, and ≥75 years. During hospitalization, young patients experienced a higher rate of in‐hospital complications (32.8% versus 23.4%, 27.4%, and 31.9%; P=0.01), but in‐hospital mortality was higher in the older group (0%, 1.6%, 2.9%, and 5%; P=0.001). Long‐term all‐cause mortality was significantly higher in the older cohort (5.6%, 6.4%, 11.3%, and 22.3%; log‐rank P<0.001), as was long‐term cardiovascular mortality (0%, 0.9%, 1.9%, and 3.2%; log‐rank P=0.01). Conclusions Young patients with TTS have a typical phenotype characterized by a higher prevalence of male sex, non‐apical ballooning patterns, and in‐hospital complications. However, in‐hospital and long‐term mortality are significantly lower in young patients with TTS. Registration URL: https://classic.clinicaltrials.gov/ct2/show/NCT04361994. Unique identifier: NCT04361994.
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesJournal of the American Heart Association;13(4)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectHomes
dc.subjectFenotip
dc.subjectMiocardi - Malalties
dc.subject.meshTakotsubo Cardiomyopathy
dc.subject.meshPhenotype
dc.subject.meshMale
dc.titleAge‐Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1161/JAHA.123.030623
dc.subject.decsmiocardiopatía de Takotsubo
dc.subject.decsfenotipo
dc.subject.decsmasculino
dc.relation.publishversionhttps://doi.org/10.1161/JAHA.123.030623
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[El-Battrawy I] Institute of Physiology, Department of Cellular and Translational Physiology and Institut für Forschung und Lehre (IFL), Molecular and Experimental Cardiology, Ruhr University Bochum, Bochum, Germany. Department of Cardiology and Angiology, Bergmannsheil University Hospitals, Ruhr University of Bochum, Bochum, Germany. [Santoro F] Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy. [Núñez-Gil IJ] Interventional, Cardiology, Cardiovascular Institute, Hospital Clínico Universitario San Carlos, Madrid, Spain. [Pätz T] Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine) and German Center for Cardiovascular Research, partner site Hamburg/Kiel/Lübeck, University Heart Center Lübeck, Lübeck, Germany. [Arcari L] Institute of Cardiology, Madre Giuseppina Vannini Hospital, Rome, Italy. [Abumayyaleh M] Institute of Physiology, Department of Cellular and Translational Physiology and Institut für Forschung und Lehre (IFL), Molecular and Experimental Cardiology, Ruhr University Bochum, Bochum, Germany. Institute of Cardiology, Madre Giuseppina Vannini Hospital, Rome, Italy. [Uribarri A] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid38348805
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record